• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征的发现史。

History of discovery of polycystic ovary syndrome.

出版信息

Adv Clin Exp Med. 2017 May-Jun;26(3):555-558. doi: 10.17219/acem/61987.

DOI:10.17219/acem/61987
PMID:28791833
Abstract

Stein and Leventhal are regarded to have been the first investigators of polycystic ovary syndrome (PCOS); however, in 1721 Vallisneri, an Italian scientist, described a married, infertile woman with shiny ovaries with a white surface, and the size of pigeon eggs. It was not until the early 1990s at a National Institute of Health (NIH) sponsored conference on PCOS that formal diagnostic criteria were proposed and afterwards largely utilized. Many scientists tried to explain the pathophysiology of PCOS and many studies were made. It is now accepted that it is multifactorial, partly genetic; however, a number of candidate genes have been postulated. Insulin resistance has been noted consistently among many women with PCOS, especially in those with hyperandrogenism, but it is not included in any of the diagnostic criteria. Now there is strong evidence that cardiovascular disease risk factors and disturbances in carbohydrate metabolism are all increased in patients with PCOS compared to the healthy population. The criteria established by a group of experts during a conference in Rotterdam held in 2003 are obligatory (The Rotterdam ESHRE/ASRM - Sponsored PCOS Consensus Workshop Group). The subsequent "Rotterdam criteria" incorporated the size and morphology, as determined by an ultrasound, of the ovary into the diagnostic criteria.

摘要

斯坦因和莱文塔尔被认为是多囊卵巢综合征(PCOS)的首批研究者;然而,在1721年,意大利科学家瓦利斯内里描述了一名已婚不孕女性,其卵巢表面光滑呈白色,大小如鸽蛋。直到20世纪90年代初,在美国国立卫生研究院(NIH)主办的一次关于PCOS的会议上,才提出了正式的诊断标准,并在之后得到广泛应用。许多科学家试图解释PCOS的病理生理学,并进行了大量研究。现在人们公认其病因是多因素的,部分与遗传有关;然而,已经提出了一些候选基因。许多PCOS女性一直存在胰岛素抵抗,尤其是那些患有高雄激素血症的女性,但胰岛素抵抗并未包含在任何诊断标准中。现在有强有力的证据表明,与健康人群相比,PCOS患者的心血管疾病风险因素和碳水化合物代谢紊乱均有所增加。2003年在鹿特丹举行的一次会议上,一组专家制定的标准具有强制性(鹿特丹ESHRE/ASRM赞助的PCOS共识研讨会小组)。随后的“鹿特丹标准”将通过超声测定的卵巢大小和形态纳入了诊断标准。

相似文献

1
History of discovery of polycystic ovary syndrome.多囊卵巢综合征的发现史。
Adv Clin Exp Med. 2017 May-Jun;26(3):555-558. doi: 10.17219/acem/61987.
2
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.临床内分泌学争议:多囊卵巢综合征的诊断:鹿特丹标准尚不成熟。
J Clin Endocrinol Metab. 2006 Mar;91(3):781-5. doi: 10.1210/jc.2005-2153. Epub 2006 Jan 17.
3
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).2003年修订的关于多囊卵巢综合征(PCOS)的诊断标准及长期健康风险的共识。
Hum Reprod. 2004 Jan;19(1):41-7. doi: 10.1093/humrep/deh098.
4
Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.多囊卵巢综合征的超声新标准:卵泡数和卵巢体积升高的可靠阈值。
Hum Reprod. 2013 May;28(5):1361-8. doi: 10.1093/humrep/det062. Epub 2013 Mar 15.
5
Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.多囊卵巢在慢性无排卵伴高雄激素血症的女性中很常见,但不能预测代谢或生殖表型。
J Clin Endocrinol Metab. 2005 May;90(5):2571-9. doi: 10.1210/jc.2004-0219. Epub 2005 Feb 15.
6
Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.多囊卵巢综合征定义的调和:卵巢卵泡数和血清抗苗勒管激素浓度与高雄激素血症的标志物聚集。
J Clin Endocrinol Metab. 2010 Sep;95(9):4399-405. doi: 10.1210/jc.2010-0334. Epub 2010 Jul 7.
7
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?2003年ESHRE/ASRM的共识解决了多囊卵巢综合征(PCOS)的诊断问题吗?还是它可以包括对卵巢基质的超声检查?
Hum Reprod. 2006 Dec;21(12):3108-15. doi: 10.1093/humrep/del306. Epub 2006 Oct 19.
8
Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.基于鹿特丹标准的多囊卵巢综合征病例与仅有少排卵/无排卵或多毛症等临床体征的女性的临床和实验室特征比较。
Arch Gynecol Obstet. 2006 Jul;274(4):227-32. doi: 10.1007/s00404-006-0173-8. Epub 2006 May 12.
9
[The role of leptin in polycystic ovary syndrome].[瘦素在多囊卵巢综合征中的作用]
Pol Merkur Lekarski. 2008 Oct;25(148):390-3.
10
Evidence-based approach for the use of ultrasound in the management of polycystic ovary syndrome.基于证据的超声在多囊卵巢综合征管理中的应用方法。
Minerva Ginecol. 2008 Feb;60(1):83-9.

引用本文的文献

1
The Hypothalamic Nuclei Implicated in the Regulation of Polycystic Ovary Syndrome: A Review of Its Clinical, Metabolic, and Endocrine Aspects.参与多囊卵巢综合征调节的下丘脑核团:临床、代谢及内分泌方面的综述
Molecules. 2025 Aug 18;30(16):3407. doi: 10.3390/molecules30163407.
2
Fetuin-B as a biomarker for metformin response in women with polycystic ovary syndrome: a prospective study.胎球蛋白-B作为多囊卵巢综合征女性二甲双胍反应的生物标志物:一项前瞻性研究。
Front Med (Lausanne). 2025 Jun 25;12:1567255. doi: 10.3389/fmed.2025.1567255. eCollection 2025.
3
Barriers and facilitators to exercise participation in women with polycystic ovary syndrome: a qualitative study.
多囊卵巢综合征女性参与运动的障碍与促进因素:一项定性研究
BMJ Public Health. 2025 Apr 9;3(1):e000707. doi: 10.1136/bmjph-2023-000707. eCollection 2025.
4
Sleep disorders and psychological comorbidities in women with polycystic ovary syndrome - a cross-sectional study.多囊卵巢综合征女性的睡眠障碍与心理共病——一项横断面研究
Arch Gynecol Obstet. 2025 May 13. doi: 10.1007/s00404-025-08049-9.
5
Hydroxychloroquine enhances insulin sensitivity and ameliorates abnormal lipid metabolism in obese women with polycystic ovary syndrome.羟氯喹可增强多囊卵巢综合征肥胖女性的胰岛素敏感性并改善脂质代谢异常。
BMC Endocr Disord. 2025 Jan 2;25(1):2. doi: 10.1186/s12902-024-01827-7.
6
Rethinking the Terminology: A Perspective on Renaming Polycystic Ovary Syndrome for an Enhanced Pathophysiological Understanding.重新思考术语:关于重新命名多囊卵巢综合征以增强对病理生理学理解的观点
Clin Med Insights Endocrinol Diabetes. 2024 Oct 28;17:11795514241296777. doi: 10.1177/11795514241296777. eCollection 2024.
7
Effect of Berberine Phytosome on reproductive, dermatologic, and metabolic characteristics in women with polycystic ovary syndrome: a controlled, randomized, multi-centric, open-label clinical trial.小檗碱磷脂复合物对多囊卵巢综合征女性生殖、皮肤和代谢特征的影响:一项对照、随机、多中心、开放标签的临床试验。
Front Pharmacol. 2023 Nov 21;14:1269605. doi: 10.3389/fphar.2023.1269605. eCollection 2023.
8
Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects.多囊卵巢综合征中的催乳素:代谢影响与治疗前景
Life (Basel). 2023 Oct 26;13(11):2124. doi: 10.3390/life13112124.
9
Impact of updated international diagnostic criteria for the diagnosis of polycystic ovary syndrome.多囊卵巢综合征诊断的更新国际诊断标准的影响
F S Rep. 2022 Dec 22;4(2):173-178. doi: 10.1016/j.xfre.2022.12.003. eCollection 2023 Jun.
10
The Effect of Metformin and Carbohydrate-Controlled Diet on DNA Methylation and Gene Expression in the Endometrium of Women with Polycystic Ovary Syndrome.二甲双胍和碳水化合物控制饮食对多囊卵巢综合征妇女子宫内膜 DNA 甲基化和基因表达的影响。
Int J Mol Sci. 2023 Apr 6;24(7):6857. doi: 10.3390/ijms24076857.